KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment?
- 19 July 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Endocrine
- Vol. 57 (3), 494-502
- https://doi.org/10.1007/s12020-017-1364-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Objective Quantification of the Ki67 Proliferative Index in Neuroendocrine Tumors of the Gastroenteropancreatic SystemThe American Journal of Surgical Pathology, 2012
- Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals Of Oncology, 2012
- Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective studyGastrointestinal Endoscopy, 2012
- Grading of Neuroendocrine Tumors With Ki-67 Requires High-quality Assessment PracticesThe American Journal of Surgical Pathology, 2012
- Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the LiverThe American Journal of Surgical Pathology, 2011
- Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumorsLaboratory Investigation, 2009
- Gastroenteropancreatic neuroendocrine tumoursThe Lancet Oncology, 2008
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemVirchows Archiv, 2006
- Ki-67 Immunoreactivity in the Differential Diagnosis of Pulmonary Neuroendocrine Neoplasms in Specimens With Extensive Crush ArtifactAmerican Journal of Clinical Pathology, 2005
- Ki-67 Immunoreactivity in the Differential Diagnosis of Pulmonary Neuroendocrine Neoplasms in Specimens With Extensive Crush ArtifactAmerican Journal of Clinical Pathology, 2005